BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection but recognition of mutant viruses is up to 10-fold reduced
M. Mohsen, M. F. Bachmann, M. Vogel, G. S. Augusto, X. Liu, X. Chang
This study compares antibody recognition of SARS-CoV-2 variants by natural infection and BNT162b2 vaccination, finding improved but reduced cross-reactivity against certain mutants.
bioRxiv · Mar 13, 2021Immunology